NICE guidance on the diagnosis, assessment and initial management of hyperparathyroidism
- People with suspected or confirmed primary hyperparathyroidism, their families and carers
- Healthcare professionals
- there is better awareness about the symptoms and healthcare professionals know when to test for it
- people with hyperparathyroidism are diagnosed without delay
- doctors have clear advice on when to offer surgery for hyperparathyroidism, and how to use tests to decide the best type of surgery
- people have follow-up checks as often as needed depending on how their condition is managed
© NICE 
NICE guidance is prepared for the National Health Service in England. All NICE guidance is subject to regular review and may be updated or withdrawn. NICE accepts no responsibility for the use of its content in this product/publication.
The information provided by NICE was accurate at the time this article was issued.
Reporting of suspected adverse reactions
Reporting suspected adverse reactions (side effects) after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals or patients are asked to report any suspected adverse reactions via the Yellow Card Scheme at yellowcard.mhra.gov.uk or search for MHRA Yellow Card in the Google Play or Apple App Store.
Disclaimer: This site is designed to offer information for general educational purposes only. The health information furnished on this site and the interactive responses are not intended to be professional advice and are not intended to replace personal consultation with a qualified physician, pharmacist, or other healthcare professional. We cannot provide individual medical advice. You must always seek the advice of a professional for questions related to a disease, disease symptoms, and appropriate therapeutic treatments.
Sharable Article Link : https://keepmeinformed.eu/Article?articleGuid=8da00395-8f76-47c5-a7d1-b9de582386be